Major depression and the use of electroconvulsive therapy (ECT) in lung transplant recipients

Psychosomatics

Volumn 46, Issue 3, 2005, Pages 244-249

  Jayaram, Geetha ^a   Casimir, Andy ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ELECTROCONVULSIVE THERAPY; EVALUATION; FEMALE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES;

EID: 17844389588     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.46.3.244     Document Type: Article

References (32)

1. National Center for Health Statistics (NCHS) Vital Statistics System
2. American Lung Association Fact Sheet
3. Lanuza DM: Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000; 118:115-122
4. Limbos MM: Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000; 118:408-416
5. Craven J: Psychiatric aspects of lung transplant. Am J Psychiatry 1990; 35:759-764
6. Singer HK, Ruchinskas RA, Riley KC, Broshek DK, Earth JT: The psychological impact of end stage lung disease. Chest 2001; 120:1246-1252
7. Thoren C: Reviewing asthma and anxiety. Respir Med 2000; 94:409-415
8. Centanni S: Psychological issues in the treatment of asthmatic patients. Respir Med 2000; 94:742-749
9. Small SP, Graydon JE: Perceived uncertainty, physical symptoms, and negative mood in hospitalized patients with chronic obstructive pulmonary disease. Heart Lung 1992; 21:568-574
10. Coffman K: Psychiatric issues in pulmonary disease. Psychiatr Clin North Am 2002; 25:89-127
11. Rabheru K: The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2001; 46:710-719
12. Dew MA: Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics 2001; 42:300-313
13. Fukunishi I: Psychiatric disorders before and after living-related transplantation. Psychosomatics 2001; 42:337-343
14. Katon W, Von Korff M, Lin E: Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990; 12:355-362
15. House R, Dubovsky SL, Penn I: Psychiatric aspects of hepatic transplantation. Transplantation 1983; 36:146-150
16. Sensky T: Psychiatric morbidity in renal transplantation. Psychother Psychosom 1989; 52:41-46
17. Lee HB, Jayaram G, Teitelbaum ML: Electroconvulsive therapy for depression in a cardiac transplant patient. Psychosomatics 2001; 42:362-364
18. Woodman CL, Vance S, Jones K: Psychiatric disorders and survival after lung transplantation. Psychosomatics 1999; 40:293-297
19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory of measuring depression. Arch Gen Psychiatry 1961; 4:561-571
20. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65-87
21. Lavretsky H, Kumar A: Methylphenidate augmentation of citalopram in elderly patients. Am J Geriatr Psychiatry 2001; 9:298-303
22. Rozans M, Dreisbach A, Lertora JJL, Kahn M: Palliative uses of methylphenidate in patients with cancer: a review. J Clinical Oncology 2002; 20:335-339
23. Ayache DC, Junior RF: Methylphenidate in a patient with depression and respiratory insufficiency. Int J Psychiatry Med 2001; 31:443-449
24. Devane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L: Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. J Clin Psychopharmacol 2004; 24:4-10
25. Ereshefsky L, Dugan D: Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine. Depress Anxiety 2000; 12(suppl 1):30-44
26. Maynaar IA, Peelers AJ, Mulder AH, Ottervanger JP: Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine. Neth J Med. 1997; 50:243-245
27. Masood GR, Karki SD, Patterson WR: Hyponatremia with venlafaxine. Ann Pharmacother 1998; 32:49-51
28. Izzedine H, Launay-Vacher V, Ciroldi M, Fardet L, Deray G: Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy. Nephron 2002; 92:944-946
29. Fink M: ECT has proved effective in treating depression. Nature 2000; 403:826
30. UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361:799-808
31. Rasmussen KG, Rummans TA, Richardson JW: Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 2002; 25:177-193
32. American Psychiatric Association: The Practice of Electroconvulsive Therapy: A Task Force Report, 2nd ed. Washington, DC, APA, 2001